| 突变型p53与其合成致死基因的研究进展 |
| |
| 引用本文： | 刘同阳,郭海强,朱美妍,黄英泽,贾舒婷,罗瑛,张继虹.突变型p53与其合成致死基因的研究进展[J].遗传,2015,37(4):321-326. |
| |
| 作者姓名： | 刘同阳 郭海强 朱美妍 黄英泽 贾舒婷 罗瑛 张继虹 |
| |
| 作者单位： | 1. 昆明理工大学生命科学与技术学院,昆明 650500;2. 昆明理工大学医学院,衰老与肿瘤分子遗传学实验室,昆明 650500 |
| |
| 基金项目： | 国家自然科学基金项目(编号：81260501,U1202221)资助 |
| |
| 摘 要： | 恶性肿瘤的靶向治疗已经成为现阶段肿瘤治疗的热点。随着人们对癌基因认知的加深,借助合成致死的方法靶向治疗肿瘤已成为针对肿瘤特异性治疗的新策略。p53基因突变在肿瘤的形成和发展过程中具有重要作用。因此,了解肿瘤中与突变型p53基因有合成致死关系的靶基因的作用方式,有助于指导由突变型p53基因诱发肿瘤的个性化治疗。与突变型p53基因具有合成致死关系的靶基因可分为细胞周期调控基因和细胞非周期调控基因,文章综述了这两类靶基因与突变型p53基因如何构成合成致死作用以及此作用的现实意义。
|
| 关 键 词： | p53 合成致死 合成致死的交互作用 肿瘤 |
| 收稿时间： | 2014-08-18 |
Synthetic lethal genes to mutant p53 |
| |
| Affiliation: | 1. School of Life Science and Biotechnology, Kunming University of Science and Technology, Kunming 650500, China;2. Laboratory of Molecular Genetics of Aging and Tumor, Medical College of Kunming University of Science and Technology, Kunming 650500, China |
| |
| Abstract: | Targeted therapy has become a powerful approach for cancer treatment. Better understanding of oncogenes as well as synthetic lethal interactions with oncogenes will lead to new strategies for tumor-specific treatment. It is well known that mutant p53 plays an important role in tumorigenesis and tumor development. Thus, understanding the synthetic lethal relationship between p53 mutations and interacting genes in tumor is critical for the personalized treatments of p53 mutant tumors. Synthetic lethal genes to mutant p53 can be divided into cell cycle regulators and non-cell cycle regulators. This paper review show these two types of target genes contribute to synthetic lethal interactions with p53 mutations and potential applications of these interactions in anticancer therapy. |
| |
| Keywords: | p53 synthetic lethality synthetic lethal interactions tumor |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《遗传》浏览原始摘要信息 |
|
点击此处可从《遗传》下载全文 |
|
